MedPath

Sutures Versus Staples for Wound Closure in Orthopaedic Surgery

Not Applicable
Completed
Conditions
Surgical Wound Infection
Interventions
Device: Sutures
Device: Staples
Registration Number
NCT01146236
Lead Sponsor
University of Manitoba
Brief Summary

The trial is a randomized, controlled trial. Adult patients undergoing orthopaedic surgical procedures would be randomized to one of two groups for surgical wound closure, skin sutures or skin staples. The primary outcome measures would be surgical site infection indicated by the use of oral or intravenous antibiotics for suspected wound infection and/or re-operation at the same site. Patients would be followed up as per their usual post-operative course for a total of three months in the trauma and spine population and six months in the total joint arthroplasty population. It is hypothesized that wounds closed with sutures and staples will have similar infection rates as defined by the use of antibiotics or reoperation.

Detailed Description

To date, there is no clear consensus on the method that is best for closure of surgical wounds in orthopaedic surgery. Orthopaedic surgeons have a multitude of wound closure habits. A recent meta-analysis comparing staples to sutures in wound closure demonstrated a three-fold increase in infection in stapled wounds compared to sutured wounds. The studies used in the meta-analysis were primarily of poor methodological quality.

A large, well-designed randomized, controlled trial is needed to guide orthopedic surgeons in their choice of wound closure materials. This study would attempt to provide information on the use of sutures versus skin staples and the effect on the development of surgical site infections in adults undergoing orthopaedic procedures.

A parallel group randomized controlled trial with institutional review board approval will be conducted. Patients will be randomized intraoperatively to have skin wounds closed with sutures or staples. Dressings will be used to maintain blinding of participants and outcome assessors. The primary outcome measure will be infections adjudicated by a blinded data safety monitoring committee. Suspected infections will be defined by: Use of antibiotics or reoperation for infection at the operative site within three months (six months for arthroplasty subgroup) The independent review, board blinded to treatment assignment, will adjudicate suspected infections based on clinical data. A cost analysis will also be performed to compare the costs associated with wounds closed with sutures and staples from a health care institution perspective.

All data will be analyzed by a blinded epidemiologist. Dichotomous primary and secondary outcome measures will be analyzed using the Chi-squared statistic. Continuous outcome measures will be analyzed using Student's t-test. Subgroup analysis will compare infection rates using sutures versus staples in each anatomic area (upper extremity, pelvis/acetabulum, hip/femur, knee, ankle). A further subgroup analysis will be conducted comparing trauma patients to elective patients. Non-infected revision surgery will also be compared to primary surgery.

It is hypothesized that wounds closed with sutures and staples will have similar infection rates as defined by the use of antibiotics or reoperation.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
247
Inclusion Criteria
  • Adult patients (>18 years old)
  • All open orthopedic procedures
  • Largest wound >2cm in length
Exclusion Criteria
  • Open fracture
  • Known nickel allergy
  • Active infection (any site)
  • Chemotherapy during study period (1 month prior until end of follow-up)
  • Radiation therapy to surgical site (1 month prior until end of follow-up)
  • Foot surgery (any site)
  • Hand surgery (including carpal surgery)
  • Arthroscopic procedures

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
SuturesSuturesOrthopedic surgical wound closed with sutures
StaplesStaplesOrthopedic surgical wound closed with metallic staples
Primary Outcome Measures
NameTimeMethod
Surgical site infection6 months

Suspected cases will be identified by one or all of the following: use of intravenous antibiotics, use of oral antibiotics (patient self-reported), re-operation at same site. A blinded committee will adjudicate each suspected case and determine true infections using available clinical information. Agreement will be determined by vote.

Secondary Outcome Measures
NameTimeMethod
Additional healthcare contact related to their surgery6 months

As defined by self-reported visits to other healthcare professionals.

Length of stay6 months

Based on admission and discharge dates

Visual analogue pain score for suture/staple removal2 weeks post-operative

Patients will rate the pain experienced in removing the wound closure materials in clinic prior to unblinding.

Dressing changes by homecare/patient at home6 months

Defined by homecare consult records and patient self-report

Wound drainage6 months

As defined by necessity for dressing changes after 72 hours for fluid leakage

Wound necrosis6 months

Evidence of marginal skin death at the surgical site as evidenced by skin slough, blackening or liquefaction

Patient satisfaction with wound appearance6 months

Using visual analogue scale

Trial Locations

Locations (3)

Concordia Hip and Knee Institute

🇨🇦

Winnipeg, Manitoba, Canada

Health Sciences Centre

🇨🇦

Winnipeg, Manitoba, Canada

Pan Am Clinic

🇨🇦

Winnipeg, Manitoba, Canada

© Copyright 2025. All Rights Reserved by MedPath